5 unknown. 5 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Unknown 5 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Conjunctivitis: new trials by email Literature Review of Conjunctivitis trials Research Report on Conjunctivitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of TL-925 for the Treatment of Allergic Conjunctivitis TL-925, Placebo - Allergic Conjunctivitis | Phase 2 | Unknown | Telios Pharma, Inc. | 70 | 2023-11-01 | 2023-12-01 |
| Treatment of Dry Eye Disease Using Pro-ocularâ„¢ - A Proof of Concept, Safety, and Efficacy Study Pro-ocularâ„¢ Topical Gel, Placebo Topical Gel - Dry Eye Syndrome, Keratoconjunctivitis Sicca | Phase 2 | Unknown | PharmaDax Inc. | 80 | 2021-05-20 | 2021-05-14 |
| The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions Allergen(Tree, Grass, Weeds) - Allergic Rhinitis, Asthma | Phase 1 / Phase 2 | Unknown | University Hospitals Cleveland Medical Center | 245 | 2013-04-01 | 2013-06-17 |
| Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008 Mixture of probiotic bacteria and prebiotic oligosaccharide - Atopic Dermatitis, Food Hypersensitivity | Phase 2 / Phase 3 | Unknown | University of Helsinki | 1999-10-01 | 2006-10-18 | |
| Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study Tacrolimus 0.03% ointment (Protopic) - Allergic Conjunctivitis | Phase 2 | Unknown | Assaf-Harofeh Medical Center | 2007-03-05 |
Conjunctivitis, Allergic (4) · Asthma (2) · Dermatitis, Atopic (1) · Dry Eye Syndromes (1) · Food Hypersensitivity (1) · Keratoconjunctivitis Sicca (1) · Rhinitis, Allergic (1) · Rhinitis, Allergic, Seasonal (1)
Conjunctival Diseases (5) · Eye Diseases (5) · Hypersensitivity (4) · Hypersensitivity, Immediate (4) · Immune System Diseases (4) · Bronchial Diseases (2) · Lung Diseases (2) · Lung Diseases, Obstructive (2) · Nose Diseases (2) · Otorhinolaryngologic Diseases (2) · Respiratory Hypersensitivity (2) · Respiratory Tract Diseases (2) · Rhinitis (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)
Ointments (1) · Tacrolimus (1) · nabiximols (1)
Assaf-Harofeh Medical Center (1) · PharmaDax Inc. (1) · Telios Pharma, Inc. (1) · University Hospitals Cleveland Medical Center (1) · University of Helsinki (1)
United States (2) · Finland (1) · Israel (1) · Taiwan (1)
David Zadok, MD (1) · Devi K Jhaveri, D.O. (1) · Erkki Savilahti, Professor (1) · Haig Tcheurekdjian, M.D. (1) · Peichun Kuo (1)
PMID 18595980, PMID 21771118, PMID 22093109, PMID 30326954, PMID 30472801, PMID 34857814, PMID 37438187, PMID 38687061